1 / 14

Joining a Pharmaceutical Company as the Head of a Cancer Research Laboratory

Joining a Pharmaceutical Company as the Head of a Cancer Research Laboratory. Claudia Gonçalves Amanda Kamar Loïc Gauthier Hala Zahaf. Genova – 26 July 2013. Why?. Global impact International opportunities State-of-the-art equipment Highly-qualified team

vea
Download Presentation

Joining a Pharmaceutical Company as the Head of a Cancer Research Laboratory

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Joining a Pharmaceutical Company as the Head of a Cancer Research Laboratory Claudia Gonçalves Amanda Kamar Loïc Gauthier HalaZahaf Genova – 26 July 2013

  2. Why? • Global impact • International opportunities • State-of-the-art equipment • Highly-qualified team • Focus on particular project • Stability, security

  3. Estimatednumber of new cancer cases by world area Source: Globocon, 2008

  4. Research and Development in Europe In total: • € 30,000 million invested in R&D in Europe • 700,000 people employed (116,000 in R&D)

  5. Top 10 Pharmaceutical Companies

  6. European Pharmaceutical Leaders Roche Novartis • World leader in diagnostic research for cancer • Employs 82,029 people (2012) • 22% work in R&D • #1 investor in R&D - high turnover (2011) • World leader in biomedical research • Employs 127,724 people (2012) • 48% work in R&D • 6.7 billion USD spent on R&D in 2012

  7. WHERE? • New indications in the pipeline • Phase I (27), Phase II (18), Phase III (30) • AVASTIN® (3,47 billions € turnover) • 7 R&D centers in Europe • 8 new molecules (oncology) in the pipeline • 3 new indications for AFINITOR® (2,5 billions € turnover) • 7 R&D centers in Europe

  8. Head of Anti-cancer drug research laboratory • Requirements: • PhD and Post-doc in chemistry or life science required • Minimum 15 years of relevant industry experience. • Strong leadership & communication skills Novartis Institutes for BioMedical Research (NIBR)

  9. The Road to the Top…

  10. How? • Show added value! • CV – PhD, Postdoc, international studies, technical skills, multilingual • Cover letter – knowledge of company, research experience, interest in the position • Email or call a contact • Interview – focus on body language and communication

  11. Principal Contacts • Sylvie Dejager • Novartis Pharma SAS • Sylvie.Dajager@novartis.com • Principal Medical and Scientific Expert (Researcher) • PhD – Molecular Biology and Endrocinology • NiclasHitziger • Roche Diagnostics • niclas.hitziger@ki.se • International Product Manager • Previously Senior Team Leader and Group Leader • PhD & Postdoc – Molecular Biology

  12. The Vision • Impact global health issues – especially cancer • Opportunity to participate in growing market • Train other people from developing countries and contribute to the spread of the knowledge

  13. acknowledgement • Sandrine Lacombe • Mario Rocca • Nicolas Rabasso • Ivan Coste-Maniere • Giorgio Musso • Ryszard Naskręcki • Dorota Piontek • Schanzenbach Dirk • Bohdan Skalski • Carlos Perreira

  14. Current Job Offers • Research Investigator in Oncology (Novartis) • Supervise 2-3 associates • PhD in life science required • Strong leadership & communication skills • Senior Scientist for Discovery Oncology (Roche) • “developing a mechanistic understanding of tumor cell sensitivity and resistance to molecularly-targeted anti-cancer agents” • PhD and Post-doc experience required • Outstanding written & oral communication skills

More Related